Name: | Osiris Therapeutics |
---|---|
Link: | http://informagen.com/Resource_Informagen/report.php?mrn=1031 |
Description: | Osiris Therapeutics lead program provides MSC support for hematopoietic stem cell transplantation (HSCT) after chemotherapy or radiation therapy. The cardiac program uses MSCs to improve heart function following myocardial infarction (MI) and congestive heart failure (CHF). In orthopedic applications, MSCs may be useful in regenerating meniscal tissue in the weeks following surgery for knee injuries, thus preventing arthritis. |
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
OECD Biotechnology Topic - Organisation for Economic Co-operation and Development
Biotechnology Events - Current biotechnology events
Nanozyme-enabled nanodecoys: A new strategy for fighting urinary tract infections
New understanding of ancient genetic parasite may spur medical breakthroughs